Submit Deal

TAKEDA VENTURES

Summary

TVI's mission is to identify, help create and support the development of therapeutic innovation.

Deals Overview

Total Deals6

Valued Deals6

Total Value£ 2.54 B

Avg. Deal Size£ 423 M

Market Context

Senior Management

Christophe Weber
President and CEO
Milano Furuta
Chairman
Marcello Agosti
Global Business Development Officer

Senior Management

Christophe Weber
President and CEO
Milano Furuta
Chairman
Marcello Agosti
Global Business Development Officer

Sort

05 Nov 2020|United States|Biotechnology

Target: VELOSBIO INC

Bidder: MERCK & CO

17 Service Providers

4 Target | 4 Bidder | 9 Vendor

55 Dealmakers

20 Target | 9 Bidder | 26 Vendor

£ 2.12 B

Value

09 Nov 2020|United States|Pharmaceuticals

Target: EMENDO BIOTHERAPEUTICS

Bidder: ANGES

4 Service Providers

1 Target | 3 Bidder

4 Dealmakers

2 Target | 2 Bidder

£ 111 M

Value

24 Feb 2021|United States|Biotechnology

Target: XILIO THERAPEUTICS

Bidder: RIVERVEST VENTURE PARTNERS

3 Service Providers

1 Target | 2 Bidder

3 Dealmakers

1 Target | 2 Bidder

£ 64 M

Value

14 Apr 2022|United States|Pharmaceuticals

Target: BE BIO

Bidder: ATLAS VENTURE LP

9 Service Providers

3 Target | 6 Bidder

10 Dealmakers

3 Target | 7 Bidder

£ 99 M

Value

07 Feb 2022|United States|Medical Equipment

Target: KONEKSA HEALTH

Bidder: SPRING MOUNTAIN CAPITAL

5 Service Providers

3 Target | 2 Bidder

5 Dealmakers

3 Target | 2 Bidder

£ 37 M

Value

05 Jan 2023|United States|Biotechnology

Target: ENSOMA

Bidder: ARIX BIOSCIENCE

19 Service Providers

3 Target | 16 Bidder

19 Dealmakers

3 Target | 16 Bidder

£ 108 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy